Sabine Hildebrandt, MD
William Seidelman, MD
Arthur Caplan, PhD
A recurring assertion in the ongoing debate on abortion in the United States is the statement that pregnancy is an uncommon consequence of rape. Rep. Trent Franks, R-Ariz., has recently argued on the floor of the House of Representatives that an exception for rape wasn’t necessary in a proposed law banning abortions after 20 weeks because “the incidence of rape resulting in pregnancy are very low.”
Why do so many Americans believe this claim? Where does it come from?
According to some, the idea that you can’t get pregnant during a rape comes from research done by the Nazis on female prisoners by physicians in Germany during World War II.…
Arthur Caplan, Ph.D.
Among the greatest failures in American public health—and the list is a long one—is the rise in the incidence of cervical cancer. Incredibly, cancers caused by human papillomavirus rose in the past decade. From 2000 to 2009 rates of oral, vulva and anal cancers increased, according to a recent study by the National Cancer Institute. What makes this grim fact a notable public health failure is that we have not one but two vaccines that can greatly diminish these cancers. Both Merck and GSK market HPV vaccines–Gardasil and Cervarix. Gardisal has been around since 2006. So given the preventive power of the vaccines, why the upward trend in cancer?…
by Arthur L. Caplan
When a bridge collapses in an American city or a mine implodes, it does not take long before government gets in motion to figure out what to do about the problem. We see the carnage and demand action.
When a federal agency charged with protecting your health and safety is found grossly deficient, the response, sadly, is mainly talk.
hat is because it is hard to see where the victims are and, without them, it is hard to get the problem fixed. But when it comes to the Food and Drug Administration, we had better demand repairs.…
by Arthur L. Caplan
The recent death of Jolee Mohr is likely to have a seismic impact on the future of gene therapy research.
Biotech companies, private investors and government funders will shy away from sponsoring further research because Mohr died while a subject in an experiment using genetic engineering to treat disease.
But giving up on gene therapy is not the right lesson to learn from this tragedy.
Mohr had rheumatoid arthritis, an immune system disorder that caused pain and stiffness in her joints.
By using HUMIRA, a relatively new anti-inflammatory drug made by Abbott Laboratories, she was able to keep her symptoms under control.…